Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Amortization of Deferred Charges (2016 - 2024)

Merit Medical Systems' Amortization of Deferred Charges history spans 14 years, with the latest figure at $1.5 million for Q3 2024.

  • For Q3 2024, Amortization of Deferred Charges rose 423.76% year-over-year to $1.5 million; the TTM value through Sep 2024 reached $5.4 million, up 503.8%, while the annual FY2023 figure was $1.7 million, 184.27% up from the prior year.
  • Amortization of Deferred Charges for Q3 2024 was $1.5 million at Merit Medical Systems, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.5 million in Q1 2024 and bottomed at $151000.0 in Q1 2020.
  • The 5-year median for Amortization of Deferred Charges is $151000.0 (2020), against an average of $418947.4.
  • The largest annual shift saw Amortization of Deferred Charges plummeted 94.91% in 2020 before it surged 878.15% in 2024.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $151000.0 in 2020, then changed by 0.0% to $151000.0 in 2021, then changed by 0.0% to $151000.0 in 2022, then skyrocketed by 544.37% to $973000.0 in 2023, then soared by 51.8% to $1.5 million in 2024.
  • Per Business Quant, the three most recent readings for MMSI's Amortization of Deferred Charges are $1.5 million (Q3 2024), $1.5 million (Q2 2024), and $1.5 million (Q1 2024).